Works about NEUROFIBROMATOSIS


Results: 2120
    1
    2
    3
    4
    5
    6
    7

    Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 1, p. 117, doi. 10.1007/s11060-016-2276-9
    By:
    • Morris, Katrina;
    • Golding, John;
    • Blesing, Claire;
    • Evans, D.;
    • Ferner, Rosalie;
    • Foweraker, Karen;
    • Halliday, Dorothy;
    • Jena, Raj;
    • McBain, Catherine;
    • McCabe, Martin;
    • Swampillai, Angela;
    • Warner, Nicola;
    • Wilson, Shaun;
    • Parry, Allyson;
    • Afridi, Shazia
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Meningiomas and neurofibromatosis.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 99, n. 3, p. 341, doi. 10.1007/s11060-010-0339-x
    By:
    • Goutagny, Stéphane;
    • Kalamarides, Michel
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Recommendations of the Polish Sarcoma Group on diagnostic-therapeutic procedures and control in patients with type 1 neurofibromatosis (NF1) and the associated malignant neoplasm of peripheral nerve sheaths.

    Published in:
    Nowotwory, 2022, v. 72, n. 2, p. 106, doi. 10.5603/NJO.2022.0018
    By:
    • Rutkowski, Piotr;
    • Raciborska, Anna;
    • Szumera-Ciećkiewicz, Anna;
    • Sobczuk, Paweł;
    • Spałek, Mateusz;
    • Koseła-Paterczyk, Hanna;
    • Ługowska, Iwona;
    • Bilska, Katarzyna;
    • Gos, Monika;
    • Ryś, Janusz;
    • Chmielik, Ewa;
    • Tysarowski, Andrzej;
    • Zaborowski, Konrad;
    • Oczko-Wojciechowska, Małgorzata;
    • Castaneda-Wysocka, Patrycja;
    • Makuła, Donata;
    • Zdzienicki, Marcin;
    • Ziętek, Marcin;
    • Fonrobert, Piotr;
    • Dolecki, Kamil
    Publication type:
    Article